Results Found (497)
April 15, 2008
Yissum's spin-off Nanolymf- A breakthrough drug delivery technology

The Israeli start-up company, Nanolymf Ltd, believes its technology has the potential to allow the oral administration of some of the biggest intravenous and injectable drugs on today’s market. 

April 14, 2008
Doctors hope to check patients with micro radio antennas

Instead of asking friends "How do you feel?" or doctors examining patients, one day such queries and examinations may be replaced by tiny radio antennas implanted under the skin to act as remote sensors of humans' emotional, physiological state....

April 9, 2008
Yissum's partner PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May...

Recent research conducted by Dr. Hermona Soreq and co-workers at the

Alexander Silberman Life Sciences Institute at The Hebrew University of

Jerusalem, in collaboration with PharmAthene, examined the role of rBChE in

the prevention of amyloid...

April 9, 2008
Yissum spin-off Novagali Pharma Announces the Launch of Cationorm

The innovative cationic emulsion for the treatment of dry eye symptoms is the first product developed from its pipeline to be marketed 


April 6, 2008
Yissum revenue rises 27%

Yissum Technology Transfer Company of the Hebrew University of Jerusalem ended 2007 with $51 million revenue, 27% more than in 2006. 

April 6, 2008
Yissum spin-off CollPlant raises $8.3m

The company raised the finance from Docor International, Moshe (Mori) Arkin and a number of undisclosed institutional investors.


March 23, 2008
Forbes- Celebrating Israel's 60th Anniversary (Hebrew)

Nava Swersky Sofer congratulating Israel on it's 60th anniversary on a special Forbes edition. 

March 22, 2008
Health Scan: Hebrew U. makes genetic database available

The unique case-controlled DNA database for genetic association studies will allow the scientific community to access DNA samples directly via the Internet ( and test genes of interest.

March 11, 2008
Yissum Announces the Launch of the Hebrew University’s Genetic Resource...

The Hebrew University Genetic Resource (HUGR) platform includes 15,000 DNA samples of Ashkenazi Jews

February 28, 2008
Yissum Announces the Discovery of a Novel Small Molecule with Potent...

Scientists from the School of Pharmacy at the Hebrew University of Jerusalem discovered a novel orally available drug that prevents metastasis formation in various types of cancers. 

February 13, 2008
Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability...

Yissum spin-off Morria Biopharmaceuticals,  a biopharmaceutical company focused on the development of novel anti- inflammatory drugs, announced the preliminary safety results from its Phase I safety and tolerability study of MRX-4 in 16 patients...

January 28, 2008
Look what can be achieved with three molecules and one communication technology

Globes article portraying Israeli Technology Transfer (Hebrew)